title: Induced pluripotent stem cells for modeling neurological disorders.
abstract: Several diseases have been successfully modeled since the development of induced pluripotent stem cell (iPSC) technology in 2006. Since then, methods for increased reprogramming efficiency and cell culture maintenance have been optimized and many protocols for differentiating stem cell lines have been successfully developed, allowing the generation of several cellular subtypes in vitro. Gene editing technologies have also greatly advanced lately, enhancing disease-specific phenotypes by creating isogenic cell lines, allowing mutations to be corrected in affected samples or inserted in control lines. Neurological disorders have benefited the most from iPSC-disease modeling for its capability for generating disease-relevant cell types in vitro from the central nervous system, such as neurons and glial cells, otherwise only available from post-mortem samples. Patient-specific iPSC-derived neural cells can recapitulate the phenotypes of these diseases and therefore, considerably enrich our understanding of pathogenesis, disease mechanism and facilitate the development of drug screening platforms for novel therapeutic targets. Here, we review the accomplishments and the current progress in human neurological disorders by using iPSC modeling for Alzheimer's disease, Parkinson's disease, Huntington's disease, spinal muscular atrophy, amyotrophic lateral sclerosis, duchenne muscular dystrophy, schizophrenia and autism spectrum disorders, which include Timothy syndrome, Fragile X syndrome, Angelman syndrome, Prader-Willi syndrome, Phelan-McDermid, Rett syndrome as well as Nonsyndromic Autism.
authors.affiliation: Fabiele B Russo, Fernanda R Cugola, Isabella R Fernandes, Graciela C Pignatari, Patricia C B Beltrão-Braga, Stem Cell Lab, Department of Surgery, School of Veterinary Medicine, University of São Paulo, São Paulo 05508-270, Brazil.
authors.forename: Fabiele B
authors.initials: FB
authors.lastname: Russo
authors.affiliation: Fabiele B Russo, Fernanda R Cugola, Isabella R Fernandes, Graciela C Pignatari, Patricia C B Beltrão-Braga, Stem Cell Lab, Department of Surgery, School of Veterinary Medicine, University of São Paulo, São Paulo 05508-270, Brazil.
authors.forename: Fernanda R
authors.initials: FR
authors.lastname: Cugola
authors.affiliation: Fabiele B Russo, Fernanda R Cugola, Isabella R Fernandes, Graciela C Pignatari, Patricia C B Beltrão-Braga, Stem Cell Lab, Department of Surgery, School of Veterinary Medicine, University of São Paulo, São Paulo 05508-270, Brazil.
authors.forename: Isabella R
authors.initials: IR
authors.lastname: Fernandes
authors.affiliation: Fabiele B Russo, Fernanda R Cugola, Isabella R Fernandes, Graciela C Pignatari, Patricia C B Beltrão-Braga, Stem Cell Lab, Department of Surgery, School of Veterinary Medicine, University of São Paulo, São Paulo 05508-270, Brazil.
authors.forename: Graciela C
authors.initials: GC
authors.lastname: Pignatari
authors.affiliation: Fabiele B Russo, Fernanda R Cugola, Isabella R Fernandes, Graciela C Pignatari, Patricia C B Beltrão-Braga, Stem Cell Lab, Department of Surgery, School of Veterinary Medicine, University of São Paulo, São Paulo 05508-270, Brazil.
authors.forename: Patricia C B
authors.initials: PC
authors.lastname: Beltrão-Braga
keywords: Disease modeling; Drug screening; Human neurons; Induced pluripotent stem cells; Neurological disorders